Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial
Véronique Dièras, Hyo S. Han, Bella Kaufman, Hans Wildiers, Michael Friedländer, Jean-Pierre Ayoub, Shannon L. Puhalla, Igor Bondarenko, Mario Campone, Erik Jakobsen, Mathilde Jalving, Cristina Oprean, Markéta Palácová, Yeon Hee Park, Yaroslav Shparyk, Eduardo Yáñez, Nikhil Khandelwal, Madan G. Kundu, Matthew W. Dudley, Christine K. Ratajczak, David Maag, Banu Arun
Topics & Concepts
VeliparibCarboplatinOncologyMedicinePlaceboBreast cancerInternal medicineBRCA mutationPaclitaxelCancerChemotherapyBiologyGeneticsAlternative medicinePoly ADP ribose polymeraseCisplatinPathologyGenePolymerasePARP inhibition in cancer therapyCancer Treatment and PharmacologyAdvanced Breast Cancer Therapies